Skip to content
Screener

Pacific Biosciences of California PACB Gains Losses On Restructuring Of Debt

Gains Losses On Restructuring Of Debt at other companies

ChargePoint logo
ChargePointCHPT
$2.81M
Hillman Solutions Corp. logo
Hillman Solutions Corp.HLMN
$0+100%
Beyond Meat logo
Beyond MeatBYND
$137.16M
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$0-100%
ChargePoint logo
ChargePointCHPT
$2.81M
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$0-100%

Segments

By segment

See full
Reportable Segment$0-100%

Other financials

Income statement

See full
Revenue$39.0M-1.9%
Gross profit$12.6M-13.9%
Operating income-$44.6M+0.5%
Net income-$44.7M-6.7%
EPS (diluted)-$0.140.0%

Balance sheet

See full
Cash & equivalents$62.6M+10.5%
Total debt$61.8M+17.1%
Total equity-$33.2M-154%
Total assets$751.9M-8.9%

Cash flow

See full
Operating cash flow-$35.6M-21.1%
CapEx$1.6M+183%
Free cash flow-$37.1M-24.1%

Valuation

See full
Market cap$357.46M-5.6%
Enterprise value$356.64M-4.8%
P/S2.2×-0.2×

Profitability

See full
Gross margin36.4%+15.0pp
Operating margin-83.5%-37.4pp
Net margin-82.5%-35.5pp
FCF margin-77.5%-13.2pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio4.9×-2.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:GainsLossesOnRestructuringOfDebt.

The source filing: Pacific Biosciences of California’s 10-K, filed February 25, 2026.

Filed
Feb 25, 2026, 4:03 PM EST
Fiscal year
FY2025
Accession
0001299130-26-000034
(In thousands, except per share amounts)Years Ended December 31, 2025Years Ended December 31, 2024Years Ended December 31, 2023
Total operating expense599,641511,595387,247
Operating loss(553,861)(474,313)(334,467)
Loss on extinguishment of debt(2,033)
Gain on debt restructuring154,407
Interest expense(6,954)(13,412)(14,343)
Other income, net14,75723,78332,684
Loss before income taxes(546,058)(309,535)(318,159)
Income tax provision (benefit)318316(11,424)

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is Pacific Biosciences of California's gains losses on restructuring of debt?
Pacific Biosciences of California (PACB) reported gains losses on restructuring of debt of $0 in Q4 2025.
How has Pacific Biosciences of California's gains losses on restructuring of debt changed year-over-year?
Pacific Biosciences of California's gains losses on restructuring of debt decreased by 100.0% year-over-year, from $38.6M to $0.
What does gains losses on restructuring of debt mean?
This captures the financial impact resulting from the modification or early retirement of debt obligations. It reflects gains or losses realized when the terms of debt are altered or when debt is extinguished before its scheduled maturity. This metric is used to evaluate the company's proactive management of its capital structure and interest expense obligations.

Ask your AI about Pacific Biosciences of California's gains losses on restructuring of debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude